Harnessing gut microbiota for colorectal cancer therapy: from clinical insights to therapeutic innovations
8.0
来源：
Nature
关键字：
multi-omics
发布时间：
2025-09-30 23:50
摘要：
The article reviews the emerging role of gut microbiota in colorectal cancer (CRC) therapy, detailing how specific microorganisms can influence cancer progression and treatment outcomes. It highlights clinical trials investigating microbiome modulators, such as fecal microbiota transplantation and probiotics, which show promise in enhancing the efficacy of existing therapies. The article underscores the need for further research to integrate microbiome insights into clinical practice, aiming for improved patient outcomes in CRC management.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分
business_impact
1.0分
scientific_rigor
1.5分
timeliness_innovation
1.5分
investment_perspective
2.5分
market_value_relevance
1.0分
team_institution_background
0.0分
technical_barrier_competition
0.5分
关键证据
The article discusses specific microorganisms linked to CRC and their therapeutic implications.
It highlights clinical trials evaluating microbiome modulators in CRC treatment.
The potential of microbiome modulation to enhance chemotherapy and immunotherapy efficacy is emphasized.
真实性检查
否
AI评分总结
The article reviews the emerging role of gut microbiota in colorectal cancer (CRC) therapy, detailing how specific microorganisms can influence cancer progression and treatment outcomes. It highlights clinical trials investigating microbiome modulators, such as fecal microbiota transplantation and probiotics, which show promise in enhancing the efficacy of existing therapies. The article underscores the need for further research to integrate microbiome insights into clinical practice, aiming for improved patient outcomes in CRC management.